3-Hydroxy-3-methylglutaryl-CoA reductase (HMGCR) was found to be a genetic modifier of the risk of Alzheimer’s disease (Leduc et al., 2015). Here, HMGCR is linked to early-onset autosomal dominant Alzheimer disease.